Patents by Inventor John J. Boltralik

John J. Boltralik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-inflammatory compounds for ophthalmic use
    Patent number: 5446177
    Abstract: Anti-inflammatory compounds, a method of treating inflamed ocular tissue and compositions of these compounds are described. The compounds are derivatives and analogues of known steroid compounds (e.g., dexamethasone) and are advantageously characterized in that they do not cause any significant increase in intraocular pressure during chronic use.
    Type: Grant
    Filed: March 4, 1994
    Date of Patent: August 29, 1995
    Assignee: Alcon Laboratories, Inc.
    Inventor: John J. Boltralik
  • Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
    Patent number: 5420120
    Abstract: Topically administrable C-21 thioether glucocorticoid steroid derivatives are disclosed as effective anti-inflammatory agents for the treatment of ophthalmic inflammatory disorders. These C-21 thioether derivatives do not cause a significant increase in intraocular pressure as a side effect.
    Type: Grant
    Filed: December 17, 1993
    Date of Patent: May 30, 1995
    Assignee: Alcon Laboratories, Inc.
    Inventor: John J. Boltralik
  • Anti-inflammatory compounds for ophthalmic use
    Patent number: 5223493
    Abstract: Anti-inflammatory compounds, a method of treating inflamed ocular tissue and compositions of these compounds are described. The compounds are derivatives and analogues of known steroid compounds (e.g., dexamethasone) and are advantageously characterized in that they do not cause any significant increase in intraocular pressure during chronic use.
    Type: Grant
    Filed: March 17, 1992
    Date of Patent: June 29, 1993
    Assignee: Alcon Laboratories, Inc.
    Inventor: John J. Boltralik
  • Anti-inflammatory compounds for ophthalmic use
    Patent number: 4686214
    Abstract: Anti-inflammatory compounds and a method of treating inflamed ocular tissue utilizing these compounds are described. The steroidal actives are advantageously characterized in that they do not cause any significant increase in intraocular pressure during chronic use.
    Type: Grant
    Filed: October 30, 1985
    Date of Patent: August 11, 1987
    Assignee: Alcon Laboratories, Inc.
    Inventor: John J. Boltralik